Buscar
18/09/2025
Proportional-Assist Ventilation for Minimizing the Duration of Mechanical Ventilation
Bosma, KJ, Burns, KEA, Martin, CM, Skrobik, Y, Corts, JM, Mulligan, S, Lafreniere-Roula, M, Thorpe, KE, Montero, JCS, Chorro, IM, Rodrguez-Farr, N, Butler, R, Bentall, T, Beduneau, G, Enguerrand, P, Santos, M, Piraino, T, Spadaro, S, Montanaro, F, Basmaji, J, Campbell, E, Mercat, A, Beloncle, FM, Carteaux, G, Maraffi, T, Charbonney, E, Lecronier, M, Dres, M, Arabi, YM, Amaral, ACKB, Marinoff, N, Adhikari, NKJ, Geagea, A, Shin, P, Vaporidi, K, Kondili, E, Shahin, J, Campisi, J, Rodriguez, PO, Setten, M, Goligher, EC, Ferguson, ND, Fanelli, V, Ferreyra, G, Lellouche, F, Sibley, S, Brochard, L. Proportional-Assist Ventilation for Minimizing the Duration of Mechanical Ventilation. NEW ENGLAND JOURNAL OF MEDICINE. 2025; 393(11)DOI:10.1056/NEJMoa2505708. PMID:40513024. IF:78.500(Q1/1D).
18/09/2025
Adherence to Modified American Heart Association Cardiovascular Health Standards Is Associated With Lower Atherosclerotic Burden in Mediterranean Individuals With Type 1 Diabetes
Milad, C, Viñals, C, Perea, V, Seres-Noriega, T, Blanco-Carrasco, A, Vinagre, I, Claro, M, Solà, C, Mesa, A, Ayala, D, Conget, I, Gimenez, M, Amor, AJ. Adherence to Modified American Heart Association Cardiovascular Health Standards Is Associated With Lower Atherosclerotic Burden in Mediterranean Individuals With Type 1 Diabetes. DIABETES-METABOLISM RESEARCH AND REVIEWS. 2025; 41(6)DOI:10.1002/dmrr.70088. PMID:40965235. IF:6.000(Q1/2D).
18/09/2025
Differential Expression of Galectin-1 and Galectin-9 in Immune-Mediated Inflammatory Diseases
Valero-Martinez, C, Pardines-Ortiz, M, Montes, N, Dauden, E, Fernández-Gutierrez, B, Garcia-Planella, E, Garcia, FG, Gratacós, J, Perez-Venegas, JJ, Julia, A, Marsal, S, Lamana, A, Garcia-Vicuña, R, González-Alvaro, I, Triguero-Martinez, A. Differential Expression of Galectin-1 and Galectin-9 in Immune-Mediated Inflammatory Diseases. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(18)DOI:10.3390/ijms26189087. PMID:41009653. IF:4.900(Q1/3D).
17/09/2025
Interobserver agreement of the Taulí-pT1 classification in rectal pT1 adenocarcinoma
Gener-Jorge, C, Piñas, JCF, Garcia, ABM, Rivera, DSM, Casalots, A, Nonell, A, Espina, B, Caro-Tarragó, A, Serra-Aracil, X. Interobserver agreement of the Taulí-pT1 classification in rectal pT1 adenocarcinoma. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE. 2025; 40(1)DOI:10.1007/s00384-025-04996-6. PMID:40957973. IF:2.300(Q2/3D).
15/09/2025
Reduced circulating levels of CXCL14 are associated with cardiovascular damage in people living with HIV
Quesada-López, T, Mestres-Arenas, A, Domingo, P, Prieto, P, Mur, I, Pérez, JAH, Guimaraes, MP, Villarroya, J, Gutiérrez, MD, Mateo, MG, Domingo, JC, Planavila, A, Villarroya, F, Giralt, M, Cereijo, R. Reduced circulating levels of CXCL14 are associated with cardiovascular damage in people living with HIV. EUROPEAN JOURNAL OF PHARMACOLOGY. 2025; 1003DOI:10.1016/j.ejphar.2025.177996. PMID:40714072. IF:4.700(Q1/2D).
14/09/2025
Plasma metabolites in patients of the REDINSCOR III registry hospitalised for de novo heart failure with preserved ejection fraction: Prognostic implications of linoleamide and 2-trans,4-cisdecadienoylcarnitine levels
Delgado-Arija, M, Carmena, MDGC, Martínez-Selles, M, Guerra, JM, Valdivielso, S, González-Juanatey, JR, Rivas-Lasarte, M, Roselló-Lleti, E, Perez-Villacastin, J, Carrasquer, A, Matute-Blanco, L, Grande-Trillo, A, Crespo-Leiro, MG, Delgado, JF, Martinez-Dolz, L. Plasma metabolites in patients of the REDINSCOR III registry hospitalised for de novo heart failure with preserved ejection fraction: Prognostic implications of linoleamide and 2-trans,4-cisdecadienoylcarnitine levels. Clinical and Translational Medicine. 2025; 15(9)DOI:10.1002/ctm2.70398. PMID:40947803. IF:6.800(Q1/2D).
12/09/2025
A phase 1b randomized, multicenter, dose determination trial of zelpultide alfa (recombinant human surfactant protein D) in preterm neonates at high risk of developing bronchopulmonary dysplasia
Alonso-Ojembarrena, A, Poindexter, B, Aleem, S, Healy, H, Aguar-Carrascosa, M, Moliner-Calderón, E, Serrano-Martin, MD, Arroyo, R, Vento, M. A phase 1b randomized, multicenter, dose determination trial of zelpultide alfa (recombinant human surfactant protein D) in preterm neonates at high risk of developing bronchopulmonary dysplasia. Frontiers in Pediatrics. 2025; 13DOI:10.3389/fped.2025.1639573. PMID:41018057. IF:2.000(Q2/4D).
10/09/2025
Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline
Park, HS, del Campo, PD, Plana, MN, La Borda, JPY, Guerra-Rodriguez, M, Moreno, M, Cañete, JD. Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline. Frontiers in Medicine. 2025; 12DOI:10.3389/fmed.2025.1621313. PMID:41001393. IF:3.000(Q1/2D).